Aster DM Quality Care · NSE: ASTERDM · BSE: 540975
Q1 FY21 results · Apr–Jun 2020
Aster DM Quality Care reported revenue from operations of ₹1,760.63 crore (down 13.2% from Q1 FY20) and net loss of ₹88.59 crore for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,760.63 | 2,028.59 | −13.2% | 2,301.37 | −23.5% |
| Other income | 6.52 | 3.25 | +100.6% | 26.57 | −75.5% |
| Total income | 1,767.15 | 2,031.84 | −13.0% | 2,327.94 | −24.1% |
| Profit before share of associates & JVs and tax | (85.74) | 13.18 | Turned loss | 146.08 | Turned loss |
| Share of profit/(loss) of associates & JVs | 1.02 | (0.90) | 0.18 | ||
| Net profit for the period | (88.59) | 10.05 | Turned loss | 146.31 | Turned loss |
| Attributable to shareholders of the company | (82.93) | 3.26 | Turned loss | 131.11 | Turned loss |
| EPS, basic (₹) | (1.67) | 0.06 | Turned loss | 2.61 | Turned loss |
| Net margin (%) | -5.0 | 0.5 | 6.4 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 130.61 | 169.05 | −22.7% | 193.09 | −32.4% |
| Other income | 4.79 | 2.13 | +124.9% | 16.64 | −71.2% |
| Total income | 135.40 | 171.18 | −20.9% | 209.73 | −35.4% |
| Profit before tax | (27.51) | (16.86) | Loss widened | 0.33 | Turned loss |
| Net profit for the period | (27.52) | (16.86) | Loss widened | 0.20 | Turned loss |
| EPS, basic (₹) | (0.55) | (0.34) | Loss widened | 0.01 | Turned loss |
| Net margin (%) | -21.1 | -10.0 | 0.1 |
Consolidated
- Filed with BSE
- 13 Aug 2020, 12:13 IST
- Board meeting
- 12 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2020, 12:13 IST
- Board meeting
- 12 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE